Skip to Content

Lunesta Approval History

FDA Approved: Yes (First approved December 15, 2004)
Brand name: Lunesta
Generic name: eszopiclone
Dosage form: Tablets
Previous Name: Estorra
Company: Sepracor Inc.
Treatment for: Insomnia

Lunesta (eszopiclone) is a nonbenzodiazepine hypnotic agent indicated for the treatment of patients who experience difficulty falling asleep as well as for the treatment of patients who are unable to sleep through the night (sleep maintenance difficulty).

Development History and FDA Approval Process for Lunesta

DateArticle
Dec 15, 2004Approval Lunesta Sepracor Inc. - Treatment for Insomnia
Jul 15, 2004Sepracor Announces FDA Acceptance of Estorra NDA Resubmission and Issuance of Class 2 Review Designation
Jun 16, 2004Sepracor Announces Resubmission of Estorra NDA to FDA
Mar  1, 2004Sepracor Announces Approvable Action for Estorra (eszopiclone) for the Treatment of Insomnia and Provides Update on Launch Plans

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide